Jorge Labrador-Gomez

36PUBLICATIONS
329CO-AUTHORS
Haematological tumoursMedical mycologyNanomedicineMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Nov 04, 2026
Temporal Trends in Real-World Outcomes With CPX-351 in Secondary/High-Risk Acute Myeloid Leukemia: A PETHEMA Study.

|Oct 08, 2026
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

|Oct 06, 2026
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|May 04, 2026
Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

Pageof 6

Frequent Collaborators

9 joint publications

Pau Montesinos

8 joint publications

Mar Tormo

8 joint publications

David Martínez-Cuadrón

8 joint publications

Jon Salmanton-García